Brief: Lansen Pharmaceutical's Hou Song Resigns As Executive Director
12/10/2018 10:01
Oct 12 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* HOU SONG HAS RESIGNED AS EXECUTIVE DIRECTOR
Source text for Eikon: ID:nHKS1ShKPv
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year